Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PERCY QUATTRO in Metastatic Renal Carcinoma
NCT00291369Phase 3Completed
- Sponsor
- Centre Léon Bérard
- Start
- Dec 1999
- Modality
- Cytokines & Interferons
- Countries
- 1
01
Overview
A Phase 3 trial of aldesleukin, interferon alfa-2a in metastatic renal cell carcinoma (mRCC), sponsored by Centre Léon Bérard. Started Dec 1999; status: completed.
02
Drugs
aldesleukininterferon alfa-2a
03
Conditions
metastatic renal cell carcinoma (mRCC)
Beyond the preview
Go deeper on NCT00291369.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00291369.